BioCentury | May 18, 2009
Company News

EMO-FARM, Valeant Pharmaceuticals International deal

...Valeant acquired dermatology company EMO-FARM for $28 million in cash. EMO-FARM markets a number of products...
...and Emorect anti-inflammatory, anti-edema and analgesic gel. The company reported 2008 revenues of $12 million. EMO-FARM...
...Ltd. and Dow Pharmaceutical Sciences Inc. (see BioCentury, March 10, 2008, & Dec. 15, 2008). EMO-FARM Ltd....
Items per page:
1 - 1 of 1
BioCentury | May 18, 2009
Company News

EMO-FARM, Valeant Pharmaceuticals International deal

...Valeant acquired dermatology company EMO-FARM for $28 million in cash. EMO-FARM markets a number of products...
...and Emorect anti-inflammatory, anti-edema and analgesic gel. The company reported 2008 revenues of $12 million. EMO-FARM...
...Ltd. and Dow Pharmaceutical Sciences Inc. (see BioCentury, March 10, 2008, & Dec. 15, 2008). EMO-FARM Ltd....
Items per page:
1 - 1 of 1